Entrada Therapeutics and Pluri are identified as small-cap healthcare companies listed on the Nasdaq stock exchange.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Entrada Therapeutics and Pluri are identified as small-cap healthcare companies listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pluri Inc.
Israeli company engaged in the development of human placental adherent stromal cells for commercial use
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.
- Monte Rosa Therapeutics and Sana Biotechnology, Inc. are small-cap healthcare companies that trade on the Nasdaq stock exchange.
- Ensysce is listed on NASDAQ and received FDA Orphan Drug Designation for its CRPS therapy.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.